Cheol Ho Park
Overview
Explore the profile of Cheol Ho Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang D, Park C, Kim H, Park J, Han S, Kim J, et al.
Clin Kidney J
. 2025 Mar;
17(9):sfae248.
PMID: 40034486
Background: Bone mineral density (BMD) predicts fracture risk in patients with chronic kidney disease (CKD) and in the general population. However, few studies have investigated risk factors for bone loss...
2.
Kim J, Lim H, Park C, Kim H, Chang T, Han S
Clin J Am Soc Nephrol
. 2025 Jan;
20(3):387-396.
PMID: 39774415
No abstract available.
3.
Park C, Ko Y, Heo G, Kim B, Oh S, Han S, et al.
Clin J Am Soc Nephrol
. 2024 Dec;
20(1):72-80.
PMID: 39729594
No abstract available.
4.
Kim H, Kang M, Lim H, Park C, Kim J, Chang T, et al.
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39392785
Objective: The association between colchicine use and the primary prevention of atherosclerotic cardiovascular disease (ASCVD) remains unknown. This study aimed to explore the association between colchicine use and new development...
5.
Park C, Lim H, Kim Y, Kim J, Kim H, Chang T, et al.
Am J Nephrol
. 2024 Oct;
56(1):13-24.
PMID: 39369705
Introduction: Non-alcoholic fatty liver disease (NAFLD) has emerged as a potential indicator for cardio-metabolic risk. However, clinical implications of NAFLD in patients with chronic kidney disease (CKD) are still elusive....
6.
Park C, Koh H, Lee J, Jung H, Ha J, Kim H, et al.
Sci Rep
. 2024 Aug;
14(1):19499.
PMID: 39174619
No abstract available.
7.
Park C, Hong S, Kim S, Shin S, Kim D, Lee J, et al.
Clin Hypertens
. 2024 Jul;
30(1):20.
PMID: 39085979
Background: The target blood pressure (BP) value is unclear for diabetic kidney disease (DKD). Therefore, we aimed to evaluate the effect of strict BP control or 'on treatment' BP on...
8.
Park C, Koh H, Lee J, Jung H, Ha J, Kim H, et al.
Sci Rep
. 2024 Jun;
14(1):14284.
PMID: 38902283
Optimal strategy for volume control and the clinical implication of achieved volume control are unknown in patients with sepsis-associated acute kidney injury (AKI) receiving continuous renal replacement therapy (CRRT). This...
9.
Park C, Kim H, Park J, Chang T, Yoo T, Park S, et al.
Atherosclerosis
. 2024 May;
395:117563.
PMID: 38692977
Background And Aims: High coronary artery calcification (CAC) burden is a significant risk factor for adverse cardiovascular and kidney outcomes. However, it is unknown whether changes in the coronary atherosclerotic...
10.
Park C, Kim H, Joo Y, Park J, Chang T, Yoo T, et al.
Kidney Int
. 2023 Dec;
105(4):835-843.
PMID: 38159679
Time-in-target range (TTR) of systolic blood pressure (SBP) is determined by the proportion of time during which SBP remains within a defined optimal range. TTR has emerged as a useful...